151.25

1.01% -1.54

Inspire Medical Systems Inc (INSP)

Overview News Price History Option Chain Financials Why INSP Down? Discussions Forecast

Inspire Medical Systems Inc stock is traded at $151.25, with a volume of 309.47K. It is down -1.01% in the last 24 hours and down -1.66% over the past month. Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Previous Close:

$152.79

Open:

$153.38

24h Volume:

309.47K

Relative Volume:

0.62

Market Cap:

$4.71B

Revenue:

$802.80M

Net Income/Loss:

$53.51M

P/E Ratio:

87.43

EPS:

1.73

Net Cash Flow:

$91.12M

1W Performance:

-5.36%

1M Performance:

-1.66%

6M Performance:

-23.07%

1Y Performance:

-13.26%

1-Day Range:

$151.25

$155.00

1-Week Range:

$133.32

$163.35

52-Week Range:

$123.00

$225.00

Inspire Medical Systems Inc Stock (INSP) Company Profile

Name

Inspire Medical Systems Inc

Sector

Healthcare (1153)

Industry

Medical Devices (157)

Phone

763-957-5037

Address

5500 WAYZATA BLVD, GOLDEN VALLEY

Employee

1,246

Twitter

@inspiresleep

Next Earnings Date

2025-02-10

Latest SEC Filings

INSP's Discussions on Twitter

Compare INSP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INSP Inspire Medical Systems Inc	151.25	4.71B	802.80M	53.51M	91.12M	1.73
ABT Abbott Laboratories	133.24	231.09B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.86	155.24B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	380.92	144.54B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	83.48	108.82B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	73.68	44.31B	5.54B	4.18B	623.10M	7.00

Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-20-24	Upgrade	BofA Securities	Neutral → Buy
May-08-24	Downgrade	BofA Securities	Buy → Neutral
Apr-19-24	Initiated	RBC Capital Mkts	Outperform
Mar-19-24	Initiated	Morgan Stanley	Overweight
Feb-06-24	Resumed	KeyBanc Capital Markets	Overweight
Jan-19-24	Initiated	Jefferies	Buy
Jan-02-24	Downgrade	Stifel	Buy → Hold
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Apr-14-23	Initiated	Mizuho	Buy
Mar-29-23	Initiated	UBS	Buy
Dec-13-22	Upgrade	Goldman	Neutral → Buy
Dec-13-22	Initiated	KeyBanc Capital Markets	Overweight
Apr-13-22	Initiated	Truist	Buy
Apr-06-22	Initiated	Wolfe Research	Peer Perform
Mar-02-22	Resumed	BofA Securities	Buy
Jan-04-21	Downgrade	BofA Securities	Buy → Neutral
Dec-15-20	Downgrade	Goldman	Buy → Neutral
Nov-03-20	Upgrade	BofA Securities	Neutral → Buy
Nov-03-20	Upgrade	Oppenheimer	Underperform → Perform
Sep-22-20	Initiated	JP Morgan	Overweight
Sep-02-20	Initiated	Robert W. Baird	Outperform
Aug-06-20	Downgrade	BofA Securities	Buy → Neutral
Jul-15-20	Initiated	Goldman	Buy
Jun-18-20	Reiterated	Piper Sandler	Overweight
May-18-20	Initiated	Lake Street	Buy
Apr-28-20	Upgrade	BofA/Merrill	Neutral → Buy
Apr-09-20	Initiated	Piper Sandler	Overweight
Jan-28-20	Initiated	Oppenheimer	Underperform
Jan-27-20	Initiated	Oppenheimer	Underperform
Nov-06-19	Upgrade	Berenberg	Sell → Hold
Feb-05-19	Initiated	Dougherty & Company	Buy
Nov-28-18	Initiated	Berenberg	Sell
Oct-29-18	Initiated	Leerink Partners	Outperform
May-29-18	Initiated	Guggenheim	Buy
May-29-18	Initiated	Stifel	Buy
May-29-18	Initiated	Wells Fargo	Outperform

View All

Inspire Medical Systems Inc Stock (INSP) Latest News

May 09, 2025

Inspire Medical Systems, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationINSP - ACCESS Newswire

May 09, 2025

Investors Who Lost Money on Inspire Medical Systems, Inc. (INSP) Should Contact Levi & Korsinsky About Pending Class Action – INSP - ACCESS Newswire

May 09, 2025

May 08, 2025

Inspire medical systems outlines full launch of Inspire V with 17%-19% 2025 revenue growth target - MSN

May 08, 2025

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance

May 08, 2025

Inspire Medical Systems, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - Yahoo Finance

May 08, 2025

May 07, 2025

All You Need to Know About Inspire (INSP) Rating Upgrade to Buy - Yahoo Finance

May 07, 2025

Inspire Medical Systems (INSP) Target Price Lowered by Morgan St - GuruFocus

May 07, 2025

Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know - Yahoo Finance

May 07, 2025

Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

May 06, 2025

INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts - Yahoo Finance

May 06, 2025

Inspire Medical Systems (INSP) Target Price Lowered by Morgan Stanley | INSP Stock News - GuruFocus

May 06, 2025

JP Morgan Maintains Overweight Rating, Lowers PT for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus

May 06, 2025

Inspire Medical Systems (INSP) Price Target Lowered by Wells Fargo | INSP Stock News - GuruFocus

May 06, 2025

Inspire Medical (INSP): Morgan Stanley Updates Price Target Amid - GuruFocus

May 06, 2025

Inspire Medical Systems (INSP) Target Price Raised by Baird | IN - GuruFocus

May 06, 2025

Inspire Medical (INSP) Price Target Increased by Baird | INSP St - GuruFocus

May 06, 2025

Morgan Stanley Cuts Price Target on Inspire Medical Systems to $200 From $220, Keeps Overweight Rating - marketscreener.com

May 06, 2025

Inspire Medical Systems’ revenue up 23% to USD 201.3M in Q1 2025 - Medical Buyer

May 06, 2025

Inspire Medical (INSP) Faces Price Target Reduction Amid Mid-Yea - GuruFocus

May 06, 2025